Monopar Therapeutics Inc. buy BiotechBee
Start price
06:09
/
80%
€92.40
Target price
30.09.28
€170.00
Performance (%)
-0.11%
Price
18:13
€93.40
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Monopar Therapeutics Inc. is nearly unchanged. This prediction currently runs until 30.09.28. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Monopar Therapeutics Inc. | -0.11% |
| iShares Core DAX® | 2.591% |
| iShares Nasdaq 100 | -0.915% |
| iShares Nikkei 225® | 0.145% |
| iShares S&P 500 | -0.367% |
According to BiotechBee what are the pros and cons of Monopar Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Monopar Therapeutics Inc. diskutieren
Buy mit Kursziel 170,0